TY - JOUR
T1 - Photoprotective effects of sphingomyelin-containing milk phospholipids in ultraviolet B–irradiated hairless mice by suppressing nuclear factor-κB expression
AU - Ahn, Yejin
AU - Kim, Min G.
AU - Choi, Yong J.
AU - Lee, Sang J.
AU - Suh, Hyung J.
AU - Jo, Kyungae
N1 - Funding Information:
This research was supported by Solus Advanced Materials Co., Ltd. (Yongin, Korea) and Holistic Bio Co., Ltd., Korea (Seongnam, Korea; Q2026771). Conceptualization: H. J. Suh and K. Jo; data curation: M. G. Kim; formal analysis: M. G. Kim and K. Jo; funding acquisition: Y. J. Choi and S. J. Lee; investigation: K. Jo; methodology: H. J. Suh; project administration: Y. Ahn; resources: Y. J. Choi and S. J. Lee; software: M. G. Kim; supervision: H. J. Suh and K. Jo; validation: Y. Ahn; visualization: M. G. Kim; writing–original draft: Y. Ahn, H. J. Suh, and K. Jo; writing–review and editing: Y. Ahn, M. G. Kim, Y. J. Choi, S. J. Lee, H. J. Suh, and K. Jo. The data that support the findings of this study are available from the corresponding author upon reasonable request. The authors have not stated any conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
Funding Information:
This research was supported by Solus Advanced Materials Co. Ltd. (Yongin, Korea) and Holistic Bio Co. Ltd. Korea (Seongnam, Korea; Q2026771). Conceptualization: H. J. Suh and K. Jo; data curation: M. G. Kim; formal analysis: M. G. Kim and K. Jo; funding acquisition: Y. J. Choi and S. J. Lee; investigation: K. Jo; methodology: H. J. Suh; project administration: Y. Ahn; resources: Y. J. Choi and S. J. Lee; software: M. G. Kim; supervision: H. J. Suh and K. Jo; validation: Y. Ahn; visualization: M. G. Kim; writing?original draft: Y. Ahn, H. J. Suh, and K. Jo; writing?review and editing: Y. Ahn, M. G. Kim, Y. J. Choi, S. J. Lee, H. J. Suh, and K. Jo. The data that support the findings of this study are available from the corresponding author upon reasonable request. The authors have not stated any conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
Publisher Copyright:
© 2022 American Dairy Science Association
PY - 2022/3
Y1 - 2022/3
N2 - Ceramide-containing phospholipids improve skin hydration and barrier function and are ideal for use in skin care products. In this study, we evaluated the photoprotective effect of milk phospholipids on the skin condition of UVB-irradiated hairless mice. Skin parameters were assessed following oral administration of milk phospholipids. The UVB irradiation induced photoaging in mice. The animals were divided into 5 groups: a control group (oral administration of saline with no UBV irradiation), UVB group (oral administration of saline with UVB irradiation), and 3 UVB irradiation groups receiving the milk phospholipids at 3 different concentrations of oral administration, 50 mg/kg (ML group), 100 mg/kg (MM group), and 150 mg/kg (MH group), for 8 wk. An increase in skin hydration and transepidermal water loss were improved in the 150 mg/kg of milk phospholipid–administered group. Hematoxylin and eosin staining revealed a decrease in epidermal thickness in the milk phospholipid–administered groups (50, 100, and 150 mg/kg of body weight). In particular, the 100 and 150 mg/kg groups showed significant changes in the area, length, and depth of the wrinkles compared with the UVB group. Moreover, the gene expression of matrix metalloproteins was attenuated, and that of proinflammatory cytokines, especially tumor necrosis factor-α, was significantly reduced in the milk phospholipid–administered groups than in the UVB group. The reduced ceramide and increased sphingosine-1-phosphate levels in the skin tissue due to UVB exposure were restored to levels similar to those of the control group following milk phospholipid administration. These results were confirmed to be due to the downregulation of protein expression of nuclear factor kappa-B (NF-κB) and phosphorylated IκB-α (inhibitor of κB α). Collectively, oral administration of milk phospholipids improves skin health through a synergistic effect on photoprotective activity.
AB - Ceramide-containing phospholipids improve skin hydration and barrier function and are ideal for use in skin care products. In this study, we evaluated the photoprotective effect of milk phospholipids on the skin condition of UVB-irradiated hairless mice. Skin parameters were assessed following oral administration of milk phospholipids. The UVB irradiation induced photoaging in mice. The animals were divided into 5 groups: a control group (oral administration of saline with no UBV irradiation), UVB group (oral administration of saline with UVB irradiation), and 3 UVB irradiation groups receiving the milk phospholipids at 3 different concentrations of oral administration, 50 mg/kg (ML group), 100 mg/kg (MM group), and 150 mg/kg (MH group), for 8 wk. An increase in skin hydration and transepidermal water loss were improved in the 150 mg/kg of milk phospholipid–administered group. Hematoxylin and eosin staining revealed a decrease in epidermal thickness in the milk phospholipid–administered groups (50, 100, and 150 mg/kg of body weight). In particular, the 100 and 150 mg/kg groups showed significant changes in the area, length, and depth of the wrinkles compared with the UVB group. Moreover, the gene expression of matrix metalloproteins was attenuated, and that of proinflammatory cytokines, especially tumor necrosis factor-α, was significantly reduced in the milk phospholipid–administered groups than in the UVB group. The reduced ceramide and increased sphingosine-1-phosphate levels in the skin tissue due to UVB exposure were restored to levels similar to those of the control group following milk phospholipid administration. These results were confirmed to be due to the downregulation of protein expression of nuclear factor kappa-B (NF-κB) and phosphorylated IκB-α (inhibitor of κB α). Collectively, oral administration of milk phospholipids improves skin health through a synergistic effect on photoprotective activity.
KW - milk phospholipid
KW - nuclear factor-κB (NF-κB)
KW - photoprotective activity
KW - ultraviolet B irradiation
UR - http://www.scopus.com/inward/record.url?scp=85122334886&partnerID=8YFLogxK
U2 - 10.3168/jds.2021-21192
DO - 10.3168/jds.2021-21192
M3 - Article
C2 - 34998560
AN - SCOPUS:85122334886
SN - 0022-0302
VL - 105
SP - 1929
EP - 1939
JO - Journal of Dairy Science
JF - Journal of Dairy Science
IS - 3
ER -